Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAPEO.L Regulatory News (APEO)

  • There is currently no data for APEO

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Estimated NAV at 30 April 2022

16 May 2022 07:00

RNS Number : 5024L
abrdn Private Equity Opp Trst plc
16 May 2022
 

abrdn Private Equity Opportunities Trust plc

Legal Entity Identifier (LEI): 2138004MK7VPTZ99EV13

 

16 May 2022

abrdn Private Equity Opportunities Trust plc ("APEO" or "the Company") announces its estimated net asset value ("NAV") at 30 April 2022

· Estimated NAV at 30 April 2022 was 704.3 pence per share (estimated NAV at 31 March 2022 was 706.1 pence per share)

· First interim dividend of 3.6 pence per share paid on 22 April 2022

· APEO received £22.7 million of distributions and paid £18.0 million of drawdowns during the month of April

· Two new primary commitments to announce from the month of April

· Outstanding commitments of £669.4 million at 30 April 2022

· Cash balances were £28.0 million at 30 April 2022

 

APEO's valuation policy for private equity funds and co-investments is based on the latest valuations reported by the managers of the funds and co-investments in which the Company has interests. In the case of APEO's valuation at 30 April 2022, excluding new investments, 97.0% by value of the portfolio valuations were dated 31 December 2021. The value of the portfolio is therefore calculated as the 31 December 2021 valuation, adjusted for subsequent cashflows over the period to 30 April 2022.

 

Estimated NAV

At 30 April 2022, APEO's estimated NAV was 704.3 pence per share (estimated net assets £1,082.9 million), representing a 0.3% per share decrease from the estimated NAV at 31 March 2022 of 706.1 pence per share (estimated net assets £1,085.6 million). The 1.8 pence decrease in NAV per share reflected losses arising primarily from a 0.6% depreciation in the euro versus sterling during April, in addition to the first interim dividend payment of 3.6 pence per share on 22 April 2022. The cash cost of the first interim dividend was £5.5 million.

 

Drawdowns and distributions

APEO received £22.7 million of distributions and paid £18.0 million of drawdowns during the month of April. The distributions received generated realised gains and income of £7.9 million.

 

Investment activity

A new primary commitment of €30.0 million was made to Nordic Capital XI, a fund which focuses on medium to large-sized buyout deals in Northern Europe, principally in the Healthcare, Technology & Payments and Financial Services sectors.

A primary commitment of €30.0 million was also made to Investindustrial Growth III, a lower mid-market fund focused on niches within the Industrials, Business Services and Consumer & Leisure sectors primarily in Southern Europe.

 

Commitments

The Company had £669.4 million of outstanding commitments at 30 April 2022. The Manager believes that around £48.8 million of the Company's existing outstanding commitments are unlikely to be drawn.

 

Balance sheet and credit facility

The Company had cash balances of £28.0 million at 30 April 2022.

The Company made no repayments to or drawdowns from its syndicated revolving credit facility during the month of April, with a total of £24.3 million drawn at 30 April 2022. The remaining undrawn balance of the facility at 30 April 2022 was therefore £175.7 million. The facility is provided by Citi, Societe Generale and State Street Bank International, and it expires in December 2024.

 

Update from the Manager

On 24 February 2022, Russia launched a military offensive against Ukraine resulting in widespread sanctions on Russia and heightened security and cyber threats. The Company has no Russian, Belarussian or Ukrainian headquartered businesses in its portfolio of 595 separate underlying companies. In addition, following discussion with the private equity managers of the Company's portfolio, we estimate that these countries also relate to less than 1% of underlying portfolio company revenues.

The Manager therefore continues to believe that there is currently minimal direct risk to the Company. The Manager does however expect an indirect impact on our underlying portfolio, through for example, increased energy and raw material pricing. At this time, the expected impact on the Company's NAV cannot be determined.

The latest update from the Manager is available within the Latest News section of the Company website; www.abrdnpeot.co.uk.

 

Future announcements

The Company is expecting to announce its estimated NAV at 31 May 2022 on or around 16 June 2022.

Additional detail about APEO's NAV and investment diversification can be found on APEO's website. Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website is incorporated into, or forms part of, this announcement.

 

For further information please contact Alan Gauld at abrdn Capital Partners LLP (0131 528 4424)

Note:-

abrdn Private Equity Opportunities Trust plc is an investment company managed by abrdn Capital Partners LLP, the ordinary shares of which are admitted to listing by the UK Listing Authority and to trading on the Stock Exchange and which seeks to conduct its affairs so as to qualify as an investment trust under sections 1158-1165 of the Corporation Tax Act 2010. The Board of abrdn Private Equity Opportunities Trust plc is independent of abrdn plc and Phoenix Group Holdings.

The Company intends to release regular estimated NAV updates around ten business days after each month end. A breakdown of APEO's portfolio can be obtained in the latest monthly factsheet, which is published on APEO's website at:

www.abrdnpeot.co.uk

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVDZGMKDFVGZZM
Date   Source Headline
30th Apr 202410:48 amRNSDirector/PDMR Shareholding
29th Apr 20244:53 pmRNSChange of Name
17th Apr 20247:00 amRNSEstimated NAV at 31 March 2024
16th Apr 202410:26 amRNSDirector/PDMR Shareholding
15th Apr 20244:51 pmRNSUpdate from QuotedData
8th Apr 20247:00 amRNSTransaction in Own Shares
3rd Apr 20244:37 pmRNSQuarterly disclosure
2nd Apr 20247:00 amRNSTotal Voting Rights
27th Mar 20243:50 pmRNSResult of AGM and Investment Manager Update
19th Mar 20247:00 amRNSEstimated NAV at 29 February 2024
13th Mar 20247:00 amRNSFirst Interim Dividend
11th Mar 20247:00 amRNSTransaction in Own Shares
4th Mar 20242:07 pmEQSEdison issues update on abrdn Private Equity Opportunities Trust (APEO): Returns and buyback help narrow the discount
26th Feb 20247:00 amRNSTransaction in Own Shares
19th Feb 20247:00 amRNSTransaction in Own Shares
16th Feb 20247:00 amRNSEstimated NAV at 31 January 2024
5th Feb 20247:00 amRNSTransaction in Own Shares
31st Jan 20247:00 amRNSAnnual Financial Report
30th Jan 20241:13 pmRNSDirector/PDMR Shareholding
25th Jan 20247:00 amRNSShare Buyback Programme
17th Jan 20247:00 amRNSEstimated NAV at 31 December 2023
12th Jan 20247:00 amRNSNotice of Results
5th Jan 20249:03 amRNSQuarterly disclosure
19th Dec 20237:00 amRNSEstimated NAV at 30 November 2023
14th Dec 20231:14 pmRNSReplacement - Fourth Interim Dividend
13th Dec 20237:00 amRNSFourth Interim Dividend
15th Nov 20237:00 amRNSEstimate NAV at 31 October 2023
31st Oct 20232:32 pmRNSHolding(s) in Company
31st Oct 20232:31 pmRNSHolding(s) in Company
31st Oct 20232:30 pmRNSHolding(s) in Company
31st Oct 202310:36 amRNSDirector/PDMR Shareholding
25th Oct 202311:34 amEQSEdison issues update on abrdn Private Equity Opportunities Trust (APEO): Resilient NAV and stable balance sheet
18th Oct 20237:00 amRNSEstimated NAV at 30 September 2023
16th Oct 202311:09 amRNSStatement regarding Investment Manager
6th Oct 20234:16 pmRNSQuotedData's Weekly News & Interview
4th Oct 20239:08 amRNSQuarterly disclosure
25th Sep 20237:00 amRNSEstimate NAV at 31 August 2023
14th Sep 20237:00 amRNSThird Interim Dividend
12th Sep 20239:56 amRNSAnnual Overview from QuotedData
18th Aug 20234:11 pmRNSHolding(s) in Company
15th Aug 20237:00 amRNSEstimated NAV at 31 July 2023
1st Aug 20233:09 pmRNSDirector/PDMR Shareholding
18th Jul 202312:11 pmRNSEdison issues update on abrdn PEO Trust
17th Jul 20237:00 amRNSEstimated NAV at 30 June 2023
7th Jul 20237:00 amRNSDoc re. Half Yearly Report
5th Jul 20239:19 amRNSQuarterly disclosure
28th Jun 20239:16 amRNSHalf-year Report - Replacement
28th Jun 20237:00 amRNSHalf-year Report
20th Jun 20237:00 amRNSEstimated NAV at 31 May 2023
14th Jun 20237:00 amRNSSecond Interim Dividend

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.